Mehwish Zehravi | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Mehwish Zehravi | Molecular Biology | Best Researcher Award

Assistant Professor at Al-Tibri Medical College, Pakistan

Dr. Mehwish Zehravi is an accomplished academic and researcher specializing in pathology with a focus on stem cell culture, genetic analysis, and regenerative medicine. Currently serving as an Assistant Professor in the Department of Pathology at Al-Tibri Medical College, Karachi, she has contributed significantly to teaching, research, and clinical practices. Her expertise spans advanced laboratory techniques, including human stem cell culture, whole exome sequencing, and immunofluorescence microscopy. With a strong academic foundation, Dr. Zehravi has published in reputed journals and presented her research at notable platforms. Her work on identifying genetic mutations in muscular dystrophy patients has been recognized internationally, with findings published in the Leiden Open Variant Database. A dedicated professional, she continuously enhances her skills through workshops, certifications, and collaborative research.

Professional Profile

Education

Dr. Zehravi holds an M.Phil. in Pathology from Dow University of Health Sciences, Karachi, with a commendable CGPA of 3.48, achieved in 2020. She earned her M.B.B.S. from the same institution in 2012, securing a CGPA of 3.06. Her academic journey also includes pre-medical studies at B.A.M.M. P.E.C.H.S. Govt. College for Women, Karachi, and matriculation at St. Patrick’s Girls High School, Karachi, where she excelled with distinction. She has actively pursued professional development through various certifications, including the Certificate of Health Professional Education from Liaquat National Hospital and workshops on bioinformatics, sample size calculation, and learning management systems.

Professional Experience

Dr. Zehravi has a diverse professional background combining academic, clinical, and research expertise. Currently, she serves as an Assistant Professor at Al-Tibri Medical College, where she previously worked as a Senior Lecturer. Her teaching career is complemented by hands-on experience in various clinical settings, including roles as a Resident Medical Officer at Sambro’s Hospital, Sindh Institute of Urology and Transplantation, and Civil Hospital, Karachi. She has also contributed to the field as a researcher at the Stem Cells & Regenerative Medicine Lab at Dow University, focusing on advanced genetic studies and stem cell culture techniques. Her extensive house job experience across surgery, gynecology, pediatrics, and medicine further solidifies her clinical expertise.

Research Interests

Dr. Zehravi’s research focuses on regenerative medicine, stem cell culture, and genetic disorders. She is particularly interested in understanding the mutational profiles of diseases like muscular dystrophy and leveraging induced pluripotent stem cells for therapeutic purposes. Her work also delves into molecular and cellular biology techniques, such as transfection, PCR, flow cytometry, and sequencing technologies. She is passionate about exploring new avenues in bioinformatics and integrating advanced laboratory techniques to address complex medical challenges. Dr. Zehravi’s contributions to genetic research aim to enhance understanding and treatment options for inherited diseases, aligning her work with global scientific advancements.

Research Skills

Dr. Zehravi possesses a robust set of research skills, including expertise in human stem cell culture, transfection using episomal plasmids, and advanced genetic sequencing techniques like Sanger and whole exome sequencing. She is proficient in DNA extraction, gel electrophoresis, PCR, and flow cytometry. Her technical expertise extends to phase contrast and immunofluorescence microscopy, alongside reprogramming techniques using Neon Transfection Systems. Additionally, she is adept at statistical analysis using SPSS and reference management tools like EndNote. These skills have enabled her to make significant contributions to understanding genetic mutations and developing innovative therapeutic approaches.

Awards and Honors

Dr. Zehravi has earned recognition for her impactful research and professional accomplishments. Her study on genetic mutations in muscular dystrophy patients was the first from Pakistan to be included in the Leiden Open Variant Database, marking a milestone in global genetic research. She has also presented her research findings at prestigious conferences, such as her survey on euthanasia perspectives at Dow University. Furthermore, she has consistently demonstrated academic excellence, earning top grades throughout her educational journey. Her commitment to professional development is evident through her participation in numerous workshops, training sessions, and certifications.

Conclusion

Dr. Mehwish Zehravi is a dedicated researcher and academic whose work bridges the gap between education, clinical practice, and cutting-edge research. With a strong foundation in pathology, she has significantly contributed to the study of genetic disorders and regenerative medicine. Her innovative research, particularly in muscular dystrophy, has gained international recognition. Alongside her academic and research pursuits, Dr. Zehravi actively participates in workshops and certifications to stay updated with advancements in her field. With her exceptional skills and passion for medical research, Dr. Zehravi is a worthy candidate for the Best Researcher Award, embodying excellence, innovation, and dedication to improving healthcare outcomes.

Publication Top Notes

  1. Whole-Exome Sequencing Identifies Small Mutations in Pakistani Muscular Dystrophy Patients
    • Authors: Zehravi, M., Wahid, M., Ashraf, J., Fatima, T.
    • Year: 2021
    • Citations: 1
  2. Episomal Reprogramming of Duchenne Muscular Dystrophy Patients Derived CD3+ T Cells Towards Induced Pluripotent Stem Cells
    • Authors: Zehravi, M., Wahid, M., Ashraf, J.
    • Year: 2021
    • Citations: 1

 

Pi-Wan Cheng | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Pi-Wan Cheng | Molecular Biology | Best Researcher Award

Professor at University of Nebraska Medical Center, United States

Dr. Pi Wan Cheng is a distinguished biochemist and molecular biologist with over four decades of experience in research and academia. He currently holds a professorship at the University of Nebraska Medical Center (UNMC) and has contributed significantly to the field of glycobiology. Dr. Cheng has made pivotal advancements in understanding glycan biosynthesis and its role in health, diseases, and cancer. His work, which bridges basic and translational research, is supported by multiple research grants and patents. He has also been an active member of several professional organizations, underscoring his influence in the scientific community. Dr. Cheng’s research focuses on how glycosylation affects immune responses and cancer progression, with a special emphasis on the development of Siglec-7-based therapies for pancreatic cancer.

Professional Profile

Education:

Dr. Pi Wan Cheng obtained his Ph.D. in Biochemistry from Case Western Reserve University, Cleveland, Ohio, in 1975. Prior to that, he earned his M.S. in Biochemistry from National Taiwan University in 1968, following his B.S. in Agricultural Chemistry from the same institution in 1965. Throughout his educational journey, Dr. Cheng worked under the mentorship of prominent scientists such as Dr. Don M. Carlson and Dr. Kuo Huang Ling, which shaped his academic and professional growth in biochemistry and molecular biology.

Professional Experience:

Dr. Cheng’s career spans numerous prestigious academic institutions. He has held faculty positions at Case Western Reserve University, the University of North Carolina, and UNMC. At UNMC, he has been a professor in the Department of Biochemistry and Molecular Biology since 1995, where he was granted tenure in 1997. He also served as a research chemist at the Veterans Affairs Nebraska Western Iowa Health Care System from 2011 to 2017. His role at UNMC also includes courtesy appointments in the College of Pharmacy and the Eppley Institute for Cancer Research, where he has fostered collaborations and contributed to the institution’s research landscape.

Research Interest:

Dr. Cheng’s primary research interest lies in glycobiology, specifically the mechanisms of glycan biosynthesis and its impact on health and disease. His work focuses on understanding how glycans, particularly sialylated O-glycans, influence immune responses and contribute to the progression of diseases such as cancer. He investigates how specific glycans, induced by factors like interleukin-6 and alcohol, can protect cancer cells from immune surveillance and promote tumor growth. His innovative research is also exploring therapies targeting Siglec-7 for pancreatic cancer treatment, with potential applications in immunotherapy and cancer prevention.

Research Skills:

Dr. Cheng possesses a comprehensive skill set in biochemistry, molecular biology, and glycobiology. He is skilled in techniques related to protein biochemistry, glycan analysis, immunology, and cancer research. His expertise includes the development of molecular models to understand glycan interactions with immune cells, as well as employing various biochemical assays to assess glycan expression in disease states. Dr. Cheng’s proficiency extends to experimental design, grant writing, and leading interdisciplinary research teams. He has also contributed to the field through patents, underscoring his ability to translate fundamental discoveries into real-world applications.

Awards and Honors:

Throughout his career, Dr. Cheng has received numerous accolades for his groundbreaking research in glycobiology. His work has been supported by prestigious grants, including those from the Nebraska Department of Health and Human Services, where he has led multiple research projects related to cancer and immune function. He holds patents in biologically active molecule delivery, reflecting his innovative contributions to science. Dr. Cheng is a lifetime member of the Society for Glycobiology and the Society of Chinese Bioscientists in America, and he has been recognized for his service to the scientific community through various professional society memberships and community volunteer work.

Conclusion:

Dr. Pi Wan Cheng is a highly qualified candidate for the Best Researcher Award, with a distinguished career marked by significant research contributions in glycobiology, a track record of continuous funding, and active involvement in the scientific community. His innovative research, particularly in cancer immunology and glycosylation, holds great promise for medical advancements. While there is room for further interdisciplinary collaboration and publication visibility, his foundational work in glycobiology makes him a deserving nominee for this prestigious award.

Publication Top Notes

  1. Markers of malignant prostate cancer cells: Golgi localization of α-mannosidase 1A at GM130-GRASP65 site and appearance of high mannose N-glycans on cell surface
    • Authors: Cheng, P.-W., Davidson, S., Bhat, G.
    • Year: 2020
    • Citations: 12
  2. Inhibitory activity of salivary glycoproteins on phytohemagglutins (PHA): Possible molecules to enhance nutritional quality of red kidney beans
    • Authors: Chachadi, V.B., Nayanegali, T.R., Pujari, B.G., Inamdar, S.R., Cheng, P.-W.
    • Year: 2020
    • Citations: 3
  3. p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance
    • Authors: Miller, D.R., Ingersoll, M.A., Chatterjee, A., Oberley-Deegan, R.E., Lin, M.-F.
    • Year: 2019
    • Citations: 18
  4. Shifted Golgi targeting of glycosyltransferases and α-mannosidase IA from giantin to GM130-GRASP65 results in formation of high mannose N-glycans in aggressive prostate cancer cells
    • Authors: Bhat, G., Hothpet, V.-R., Lin, M.-F., Cheng, P.-W.
    • Year: 2017
    • Citations: 18
  5. The role of Rab6a and phosphorylation of non-muscle myosin IIA tailpiece in alcohol-induced Golgi disorganization
    • Authors: Petrosyan, A., Casey, C.A., Cheng, P.-W.
    • Year: 2016
    • Citations: 22
  6. Downregulation of the small GTPase SAR1A: A key event underlying alcohol-induced Golgi fragmentation in hepatocytes
    • Authors: Petrosyan, A., Cheng, P.-W., Clemens, D.L., Casey, C.A.
    • Year: 2015
    • Citations: 20
  7. Glycosyltransferases involved in the synthesis of MUC-associated metastasis-promoting selectin ligands
    • Authors: Chachadi, V.B., Bhat, G., Cheng, P.-W.
    • Year: 2015
    • Citations: 15
  8. Keratin 1 plays a critical role in Golgi localization of core 2 N-acetylglucosaminyltransferase M via interaction with its cytoplasmic tail
    • Authors: Petrosyan, A., Ali, M.F., Cheng, P.-W.
    • Year: 2015
    • Citations: 20
  9. Restoration of compact Golgi morphology in advanced prostate cancer enhances susceptibility to galectin-1-induced apoptosis by modifying mucin O-glycan synthesis
    • Authors: Petrosyan, A., Holzapfel, M.S., Muirhead, D.E., Cheng, P.-W.
    • Year: 2014
    • Citations: 64
  10. Golgi fragmentation induced by heat shock or inhibition of heat shock proteins is mediated by non-muscle myosin IIA via its interaction with glycosyltransferases
    • Authors: Petrosyan, A., Cheng, P.-W.
    • Year: 2014
    • Citations: 24

 

Mario D. Cordero | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Dr. Mario D. Cordero | Molecular Biology | Best Researcher Award

Principal Investigator at Pablo de Olavide University, Spain

Mario David Cordero Morales is a distinguished professional and researcher known for his contributions to [specific field/area of expertise]. With a robust academic foundation and a wealth of experience in both academia and industry, he has demonstrated an unwavering commitment to advancing knowledge and fostering innovation. His career is marked by interdisciplinary collaboration, a keen focus on applied research, and significant contributions to [specific applications or innovations]. A recipient of numerous accolades, Mario David is recognized as a leader who consistently bridges the gap between theoretical research and practical implementation.

Professional Profile

Education

Mario David Cordero Morales holds an extensive academic background that has laid the groundwork for his professional success. He earned his [degree] in [field] from [university], where he developed expertise in [key area]. Building on this, he pursued advanced studies, completing a [degree/doctorate] in [specific specialization] at [university], with a thesis focusing on [specific topic]. His educational journey also includes specialized training and certifications in [specific courses], ensuring his alignment with emerging trends and technologies.

Professional Experience

With [X years] of professional experience, Mario David has held pivotal roles in academia, research, and industry. As [current position] at [organization], he leads initiatives in [key responsibilities]. Previously, he contributed significantly as [previous roles] at [institutions/organizations], where he worked on groundbreaking projects like [specific projects]. His professional journey reflects a trajectory of increasing responsibility and influence, with a focus on [core professional themes].

Research Interests

Mario David’s research interests lie at the intersection of [fields], particularly focusing on [specific topics]. His work seeks to address critical challenges in [industry/area], leveraging [specific methodologies or technologies]. He has a strong passion for exploring [emerging topics], which has positioned him as a thought leader in [field]. Through collaboration with global researchers, Mario continues to pioneer advancements in [specific innovations].

Research Skills

Mario David is equipped with a diverse set of research skills that enhance his contributions to [field]. Proficient in [specific methodologies], he excels in [technical skills like data analysis, modeling, lab techniques]. His expertise in [tools/software] enables him to tackle complex research problems efficiently. He is adept at designing and managing large-scale projects, fostering interdisciplinary collaboration, and mentoring junior researchers to achieve excellence.

Awards and Honors

Mario David has received numerous accolades recognizing his excellence in research and professional contributions. Notable honors include [specific awards], which highlight his impact on [field]. He has also been awarded fellowships and grants from esteemed organizations like [specific institutions]. His dedication to [specific cause or innovation] has earned him accolades that underscore his status as a respected figure in [industry/field].

Conclusion

Mario David Cordero Morales is an exemplary researcher with a compelling journey and significant contributions to biomedical research. His work on inflammasomes and aging is both innovative and impactful, supported by an impressive publication record, international collaborations, and leadership in advancing knowledge in this field. While there is scope for diversification and industry engagement, his achievements, resilience, and scientific influence make him a strong contender for the Best Researcher Award.

Publication Top Notes

1.The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice

  • Authors: Muela-Zarzuela, I., Suarez-Rivero, J.M., Boy-Ruiz, D., Sanz, A., Cordero, M.D.
  • Year: 2024
  • Journal: Aging Cell
  • Volume and Issue: 23(9), e14272

2. Does NLRP1 Inflammasome Activation in Immune Cells in Kidney Transplantation Relate with Donor Organ Age?

  • Authors: Suarez-Rivero, J.M., López-Pérez, J., Astorga-Gamaza, A., Mazuecos, A., Cordero, M.D.
  • Year: 2024
  • Journal: Antioxidants and Redox Signaling
  • Volume and Issue: 41(7-9), pp. 479–487

3. NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype

  • Authors: Muela-Zarzuela, I., Suarez-Rivero, J.M., Gallardo-Orihuela, A., Mbalaviele, G., Cordero, M.D.
  • Year: 2024
  • Journal: Inflammation Research
  • Volume and Issue: 73(8), pp. 1253–1266
  • Citations: 2

4. Does Donor Age Have Effects on Senescence Biomarkers in Kidney-Transplanted Patients?

  • Authors: López-Pérez, J., Suarez-Rivero, J.M., Muela-Zarzuela, I., Mazuecos, A., Cordero, M.D.
  • Year: 2024
  • Journal: Antioxidants and Redox Signaling
  • Volume and Issue: 40(13-15), pp. 751–758
  • Citations: 1

5. Modulatory effect of Andean blackberry polyphenols on genes related to antioxidant and inflammatory responses, the NLRP3 inflammasome, and autophagy

  • Authors: Castejón-Vega, B., Kyriakidis, N.C., Alcócer-Gómez, E., Cordero, M.D., Alvarez-Suarez, J.M.
  • Year: 2024
  • Journal: Journal of Berry Research
  • Volume and Issue: 14(1), pp. 41–59
  • Citations: 1

6. How the Disruption of Mitochondrial Redox Signalling Contributes to Ageing

  • Authors: Castejon-Vega, B., Cordero, M.D., Sanz, A.
  • Year: 2023
  • Journal: Antioxidants
  • Volume and Issue: 12(4), 831
  • Citations: 8

7. L-arginine ameliorates defective autophagy in GM2 gangliosidoses by mTOR modulation

  • Authors: Castejón-Vega, B., Rubio, A., Pérez-Pulido, A.J., Alcocer-Gómez, E., Cordero, M.D.
  • Year: 2021
  • Journal: Cells
  • Volume and Issue: 10(11), 3122
  • Citations: 3

8. Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson–Gilford Progeria

  • Authors: González-Dominguez, A., Montañez, R., Castejón-Vega, B., Alcocer-Gómez, E., Cordero, M.D.
  • Year: 2021
  • Journal: EMBO Molecular Medicine
  • Volume and Issue: 13(10), e14012
  • Citations: 19

9. Glial cells (Book Chapter)

  • Authors: Williams, M., Macdonald, C., Cordero, M.D.
  • Year: 2021
  • Book: The Neuropathology of Schizophrenia
  • Pages: 221–241

10. Potential role of the mitochondria for the dermatological treatment of Papillon-Lefèvre

  • Authors: Castejón-Vega, B., Battino, M., Quiles, J.L., Cordero, M.D., Bullón, P.
  • Year: 2021
  • Journal: Antioxidants
  • Volume and Issue: 10(1), pp. 1–9, 95
  • Citations: 5

 

 

 

Hayati Türkmen | Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Prof. Hayati Türkmen | Genetics and Molecular Biology | Best Researcher Award 

Turkiye of Ege University, Turkey.

Prof. Dr. Hayati Türkmen is a distinguished academic in the field of inorganic chemistry, specializing in coordination chemistry, metal carbene complexes, catalysis, and boron chemistry. With a solid educational background, including a Ph.D. from Ege University, he has made significant contributions to the field through his extensive research and publications. His research interests span inorganic and organometallic chemistry, health sciences, and novel ligands. Dr. Türkmen has published over 100 papers and has received substantial citations, reflecting his influence in the scientific community. He has held various academic and administrative roles at Ege University, including Vice Dean and Director of Vocational School. His teaching portfolio includes advanced courses in inorganic chemistry and catalysis. Dr. Türkmen’s leadership in research and education, combined with his extensive publications and contributions to the field, highlight his eligibility for the Best Researcher Award.

Profile
Education

Dr. Hayati Türkmen completed his undergraduate studies in Chemistry at Karadeniz Technical University, Turkey, from 1993 to 1997. He then pursued a Master’s degree in Chemistry at Muğla Sıtkı Koçman University, graduating in 2000. Dr. Türkmen continued his academic journey by earning a Doctorate in Chemistry from Ege University, Turkey, between 2000 and 2007. His doctoral research focused on inorganic chemistry, which laid the foundation for his expertise in coordination chemistry, metal carbene complexes, and catalysis. This comprehensive educational background has equipped Dr. Türkmen with a solid foundation in both theoretical and applied chemistry, significantly contributing to his successful academic and research career in the field of inorganic and organometallic chemistry.

Professional Experience

Prof. Dr. Hayati Türkmen has a distinguished career in the field of chemistry, with extensive experience in both academia and administration. He has served as a Professor in the Department of Inorganic Chemistry at Ege University from 2015 to 2022, following his promotion from Associate Professor and Assistant Professor roles within the same department. His academic journey began with a role as a Research Assistant at Muğla Sıtkı Koçman University and Ege University, where he conducted significant research in coordination chemistry and catalysis. Prof. Türkmen has held several key administrative positions, including Vice Dean of the Faculty of Science at Ege University since 2022 and Director of Aliağa Vocational Training School from 2021 to 2022. His leadership extends to roles such as Head of Department at Ege University’s Graduate School of Natural and Applied Sciences and Rectorate Commissioner.

Research Interest

Dr. Hayati Türkmen’s research interests span several key areas within inorganic chemistry, including coordination chemistry, metal carbene complexes, and catalysis. His work focuses on the synthesis and application of novel ligands and metal-organic frameworks, aiming to develop advanced catalysts for industrial and environmental processes. Dr. Türkmen is particularly interested in boron chemistry and organometallic chemistry, exploring the potential of boron-based compounds in various chemical transformations. His research also extends to health sciences, where he investigates the role of metal complexes in biomedical applications. By integrating these diverse fields, Dr. Türkmen strives to advance fundamental understanding and practical applications of inorganic materials. His contributions to the development of new catalytic systems and materials have significant implications for both scientific research and industrial practice, highlighting his commitment to advancing the frontiers of chemistry and materials science.

Research Skills

Prof. Dr. Hayati Türkmen exhibits exceptional research skills across several domains of chemistry. His expertise spans coordination chemistry, metal carbene complexes, catalysis, and boron chemistry, reflecting a strong command over complex chemical systems and reactions. Dr. Türkmen is proficient in the development and application of novel ligands and metal-organic frameworks, which underpin his contributions to both fundamental research and practical applications in inorganic and organometallic chemistry. His research is characterized by meticulous experimental design and rigorous data analysis, as evidenced by his substantial publication record and citation metrics. Dr. Türkmen’s ability to synthesize new compounds and explore their catalytic properties demonstrates his innovative approach to solving chemical problems. His proficiency in mentoring graduate students and leading research projects further highlights his commitment to advancing the field through collaborative and high-impact research initiatives.

 Awards and Recognition

Dr. Hayati Türkmen has garnered significant recognition throughout his distinguished career in chemistry. His contributions to the field have been acknowledged with numerous accolades, reflecting his impact on research and education. Notably, he received the Ege University Research Award in 2021 for his outstanding achievements in inorganic chemistry and catalysis. In 2018, he was honored with the Excellence in Research Award by the Turkish Chemical Society, recognizing his innovative work in metal carbene complexes and boron chemistry. Additionally, Dr. Türkmen’s contributions to academic excellence were celebrated when he was awarded the Faculty Teaching Excellence Award in 2016, highlighting his dedication to education and mentorship. His ongoing influence and leadership in the scientific community are further evidenced by his active role in international research collaborations and editorial boards, cementing his reputation as a leading figure in his field.

Conclusion

Prof. Dr. Hayati Türkmen appears to be a strong candidate for the Research for Best Researcher Award. His extensive research output, significant citations, and leadership roles reflect a high level of accomplishment and influence in his field. Addressing areas for improvement, such as increasing citation impact and focusing research, could further strengthen his application. Overall, his achievements and contributions to science make him a compelling nominee for this prestigious award.

Publications Top Notes

  1. Efficient Synthesis of Novel 1,10 Phenanthroline-Substituted Imidazolium Salts: Exploring Their Anticancer Applications
    • Authors: Çakır, S., Ilhan, S., Atmaca, H., Türkmen, H.
    • Year: 2024
  2. Comparison of Ru(II)‒Arene Complexes Containing Naphthyl-/Quinolinyl-Substituted Ligand Vis-a-Vis Structure, Spectra and Catalytic Activity
    • Authors: Türkmen, G., Çakır, S., Batıkan Kavukcu, S., Şahin, O., Türkmen, H.
    • Year: 2024
    • Citations: 1
  3. Synthesis of Aryl-Functionalized Benzo[d,e]Benzo[4,5]Imidazo[2,1-a]Isoquinolin-7-One Derivatives: DNA Intercalation Causing Cytotoxicity
    • Authors: Türkmen, G., Çakır, S., Batıkan Kavukcu, S., Türkmen, H.
    • Year: 2024
  4. Synthesis and Characterization of Piano-Stool Ruthenium(II)-Arene Complexes of Isatin Schiff Bases: Cytotoxicity and DNA Intercalation
    • Authors: Karabıyık, H., Karaer Tunçay, A., Ilhan, S., Atmaca, H., Türkmen, H.
    • Year: 2024
  5. Ruthenium Compounds: Are They the Next-Era Anticancer Agents?
    • Authors: Kavukcu, S.B., Özverel, C.S., Kıyak, N., Vatansever, H.S., Türkmen, H.
    • Year: 2024
  6. Anticancer Effect Evaluation of Nitron Complexes
    • Authors: Tolga Özdemir, V., Batıkan Kavukcu, S., Dila Çağlar, A., Nalbantsoy, A., Türkmen, H.
    • Year: 2024
  7. Cell Death Mechanism of Organometallic Ruthenium(II) and Iridium(III) Arene Complexes on HepG2 and Vero Cells
    • Authors: Kavukcu, S.B., Ensarioğlu, H.K., Karabıyık, H., Vatansever, H.S., Türkmen, H.
    • Year: 2023
    • Citations: 3
  8. N-Alkylation and N-Methylation of Amines with Alcohols Catalyzed by Nitrile-Substituted NHC-Ir(III) and NHC-Ru(II) Complexes
    • Authors: Çakır, S., Kavukcu, S.B., Şahin, O., Günnaz, S., Türkmen, H.
    • Year: 2023
    • Citations: 11
  9. Utilization of Various Solid Leather Wastes for the Production of Blended Bricks
    • Authors: Senthil, R., Kavukcu, S.B., Çakır, S., Başaran, B., Alagumuthu, T.
    • Year: 2022
    • Citations: 10
  10. Eco-Friendly Bioenergy: New Approaches for the Effective Treatment of Tannery Fleshings
    • Authors: Rethinam, S., Aruni, A.W., Türkmen, H.
    • Year: 2021
    • Citations: 3